BUZZ-UniQure launches $200 mln equity offering after shares skyrocket

Reuters

Sep 25, 2025

** Netherlands-based drugmaker UniQure NV QURE.O looks to capitalize on its soaring share price by raising equity

** Its U .S.-listed shares on Weds finished up ~248% at $47.50 after co said its experimental gene therapy significantly slowed Huntington's disease progression in early-to-mid-stage trial

** It also announced early Weds it secured a $175 mln loan from Hercules Capital HTGC.N to support the potential U.S. launch of AMT-130

** After the bell, co commences $200 mln share offering, including pre-funded warrants

** Leerink Partners, Stifel, Van Lanschot Kempen and Guggenheim Secs are bookrunning managers for offering

** QURE has ~54.9 mln shares outstanding for about $2.6 bln current market cap

** U.S.-listed shares up 3.6% at $49.20 in extended trading

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2570038712"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2570038712\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2570038712?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-25 04:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2570038712","market":"nz","top_or_hot":-1,"title":"BUZZ-UniQure launches $200 mln equity offering after shares skyrocket","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-UniQure launches $200 mln equity offering after shares skyrocket</title></head><body><p>\n    ** Netherlands-based drugmaker UniQure NV <span>QURE.O</span> looks to capitalize on its soaring share price by raising equity\n  </p><p>\n    \n      ** Its U\n    \n    .S.-listed shares on Weds finished up ~248% at $47.50 after co said its experimental gene therapy significantly <span>slowed</span> Huntington's disease progression in early-to-mid-stage trial\n  </p><p>\n    ** It also announced early Weds it secured a $175 mln loan from Hercules Capital <span>HTGC.N</span> to support the potential U.S. launch of AMT-130\n  </p><p>\n    \n      ** After the bell, co commences $200 mln share offering, including pre-funded warrants\n    \n  </p><p>\n    \n      ** Leerink Partners, <a href=\"https://laohu8.com/S/SFB\">Stifel</a>, Van Lanschot Kempen and Guggenheim Secs are bookrunning managers for offering\n    \n  </p><p>** QURE has ~54.9 mln shares outstanding for about $2.6 bln current market cap</p><p>** U.S.-listed shares up 3.6% at $49.20 in extended trading</p><p>(Lance Tupper is a Reuters market analyst. The views expressed are his own)</p><p>((lance.tupper@tr.com 1-646-279-6380))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-UniQure launches $200 mln equity offering after shares skyrocket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-UniQure launches $200 mln equity offering after shares skyrocket\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-25 04:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-UniQure launches $200 mln equity offering after shares skyrocket</title></head><body><p>\n    ** Netherlands-based drugmaker UniQure NV <span>QURE.O</span> looks to capitalize on its soaring share price by raising equity\n  </p><p>\n    \n      ** Its U\n    \n    .S.-listed shares on Weds finished up ~248% at $47.50 after co said its experimental gene therapy significantly <span>slowed</span> Huntington's disease progression in early-to-mid-stage trial\n  </p><p>\n    ** It also announced early Weds it secured a $175 mln loan from Hercules Capital <span>HTGC.N</span> to support the potential U.S. launch of AMT-130\n  </p><p>\n    \n      ** After the bell, co commences $200 mln share offering, including pre-funded warrants\n    \n  </p><p>\n    \n      ** Leerink Partners, <a href=\"https://laohu8.com/S/SFB\">Stifel</a>, Van Lanschot Kempen and Guggenheim Secs are bookrunning managers for offering\n    \n  </p><p>** QURE has ~54.9 mln shares outstanding for about $2.6 bln current market cap</p><p>** U.S.-listed shares up 3.6% at $49.20 in extended trading</p><p>(Lance Tupper is a Reuters market analyst. The views expressed are his own)</p><p>((lance.tupper@tr.com 1-646-279-6380))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2237438978.USD","symbol_name":"Amundi Funds US Pioneer A2 (C) USD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250924:nL6N3VB10O:1","article_id":"2570038712","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2570038712","pubTimestamp":1758747258,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"** Netherlands-based drugmaker UniQure NV QURE.O looks to capitalize on its soaring share price by raising equity. .S.-listed shares on Weds finished up ~248% at $47.50 after co said its experimental gene therapy significantly slowed Huntington's disease progression in early-to-mid-stage trial. ** It also announced early Weds it secured a $175 mln loan from Hercules Capital HTGC.N to support the potential U.S. launch of AMT-130. ** After the bell, co commences $200 mln share offering, including pre-funded warrants. ** Leerink Partners, Stifel, Van Lanschot Kempen and Guggenheim Secs are bookrunning managers for offering. ** QURE has ~54.9 mln shares outstanding for about $2.6 bln current market cap** U.S.-listed shares up 3.6% at $49.20 in extended trading","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","HTGC":"海格投资","BK4504":"桥水持仓","BK4559":"巴菲特持仓","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","BK4135":"资产管理与托管银行","USB":"美国合众银行","BK4207":"综合性银行","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4588":"碎股","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","BK4585":"ETF&股票定投概念","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC"},"translate_title":"BUZZ-UniQure在股价飙升后启动2亿美元股票发行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HTGC":0.9,"USB":0.9},"content_text":"BUZZ-UniQure launches $200 mln equity offering after shares skyrocket\n    ** Netherlands-based drugmaker UniQure NV QURE.O looks to capitalize on its soaring share price by raising equity\n  \n    \n      ** Its U\n    \n    .S.-listed shares on Weds finished up ~248% at $47.50 after co said its experimental gene therapy significantly slowed Huntington's disease progression in early-to-mid-stage trial\n  \n    ** It also announced early Weds it secured a $175 mln loan from Hercules Capital HTGC.N to support the potential U.S. launch of AMT-130\n  \n    \n      ** After the bell, co commences $200 mln share offering, including pre-funded warrants\n    \n  \n    \n      ** Leerink Partners, Stifel, Van Lanschot Kempen and Guggenheim Secs are bookrunning managers for offering\n    \n  ** QURE has ~54.9 mln shares outstanding for about $2.6 bln current market cap** U.S.-listed shares up 3.6% at $49.20 in extended trading(Lance Tupper is a Reuters market analyst. The views expressed are his own)((lance.tupper@tr.com 1-646-279-6380))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}